Project Grant HT94252410008
Award Date
3/15/24
Completion Date
3/14/26
Dollars Obligated
$330K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research to investigate the role of circular RNA in regulating host defense against bacterial sepsis and lung injury. The $1,635,000 award to Trustees of Boston University Medical Campus will fund this 4-year research project from April 1, 2025 to March 31, 2029. The research aims to advance the understanding of genetic mechanisms and develop new...
The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
The Trustees of Boston University will receive $330,000 from the Defense Health Agency under a Project Grant award to identify receptors for TDP-43 that mediate cellular uptake and neurotoxicity. This research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...
The Department of the Army Medical Command awarded Boston University $999,636 under the Military Medical Research and Development federal grant program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The award will support the identification of objective brain imaging biomarkers for Gulf War Illness through exposure- and symptom-specific markers, Gulf War illness subtypes, and longitudinal patterns. Dr. Steele of Baylor College of Medicine will collaborate with Boston University researchers on...
The federal Project Grant award of $1,715,075.00 was provided by the Defense Health Agency to Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research on "The Role of TBI Derived DAMPS in Bacterial Pneumonia" over a period from September 30, 2023 to September 29, 2026. As a major academic medical center and teaching hospital, Bidmc has an extensive portfolio of federal grants and...
The U.S. Defense Health Agency awarded Boston Medical Center Corporation, doing business as BMC, a $3,499,453 project grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support the development of novel therapeutics for nephrotic syndrome, with an award period from September 15, 2023 to September 14, 2027. As a leading academic medical center and past recipient of federal research grants and contracts, BMC will leverage its...
This federal Project Grant award, valued at $153,309.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of Massachusetts to model the spread of airborne pathogens through lung-on-a-chip technology. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, and treatment. The...